LA HB766 | 2026 | Regular Session
Status
Completed Legislative Action
Sponsorship: Partisan Bill (Democrat 2)
Status: Passed on June 8 2026 - 100% progression
Action: 2026-06-08 - Effective date: 08/01/2026.
Text: Latest bill text (Chaptered) [PDF]
Sponsorship: Partisan Bill (Democrat 2)
Status: Passed on June 8 2026 - 100% progression
Action: 2026-06-08 - Effective date: 08/01/2026.
Text: Latest bill text (Chaptered) [PDF]
Summary
Provides relative to coverage for orally administered anti-cancer medications (EN +$66,367 SG EX See Note)
Title
Provides relative to coverage for orally administered anti-cancer medications (EN +$66,367 SG EX See Note)
Sponsors
Roll Calls
2026-05-29 - House - House Vote on HB 766 CONCUR IN SENATE AMENDMENTS (#1694) (Y: 97 N: 0 NV: 0 Abs: 8) [PASS]
2026-05-26 - Senate - Senate Vote on HB 766 FINAL PASSAGE (#1341) (Y: 37 N: 0 NV: 0 Abs: 2) [PASS]
2026-05-11 - House - House Vote on HB 766 FINAL PASSAGE (#1136) (Y: 93 N: 0 NV: 0 Abs: 12) [PASS]
2026-05-26 - Senate - Senate Vote on HB 766 FINAL PASSAGE (#1341) (Y: 37 N: 0 NV: 0 Abs: 2) [PASS]
2026-05-11 - House - House Vote on HB 766 FINAL PASSAGE (#1136) (Y: 93 N: 0 NV: 0 Abs: 12) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2026-06-08 | House | Effective date: 08/01/2026. |
| 2026-06-08 | House | Signed by the Governor. Becomes Act No. 833. |
| 2026-06-01 | House | Sent to the Governor for executive approval. |
| 2026-06-01 | Senate | Signed by the President of the Senate. |
| 2026-05-31 | House | Enrolled and signed by the Speaker of the House. |
| 2026-05-29 | House | Read by title, roll called, yeas 97, nays 0, Senate amendments concurred in. |
| 2026-05-27 | House | Scheduled for concurrence on 05/29/2026. |
| 2026-05-26 | House | Received from the Senate with amendments. |
| 2026-05-26 | Senate | Rules suspended. Senate floor amendments read and adopted. Read by title, passed by a vote of 37 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled. |
| 2026-05-25 | Senate | Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage. |
| 2026-05-21 | Senate | Committee amendments read and adopted. Read by title and referred to the Legislative Bureau. |
| 2026-05-20 | Senate | Reported with amendments. |
| 2026-05-13 | Senate | Read second time by title and referred to the Committee on Insurance. |
| 2026-05-12 | Senate | Received in the Senate. Read first time by title and placed on the Calendar for a second reading. |
| 2026-05-11 | House | Read third time by title, amended, roll called on final passage, yeas 93, nays 0. Finally passed, title adopted, ordered to the Senate. |
| 2026-05-11 | House | Called from the calendar. |
| 2026-05-07 | House | Scheduled for floor debate on 05/11/2026. |
| 2026-05-07 | House | Notice given. |
| 2026-05-07 | House | Read by title, returned to the calendar. |
| 2026-05-06 | House | Scheduled for floor debate on 05/07/2026. |
| 2026-05-06 | House | Read by title, amended, ordered reengrossed, passed to 3rd reading. |
| 2026-05-05 | House | Reported with amendments (18-0). |
| 2026-04-09 | House | Read by title, amended, ordered engrossed, recommitted to the Committee on Appropriations. |
| 2026-04-08 | House | Reported with amendments (10-0). |
| 2026-03-09 | House | Read by title, under the rules, referred to the Committee on Insurance. |
| 2026-02-27 | House | First appeared in the Interim Calendar on 2/27/2026. |
| 2026-02-27 | House | Under the rules, provisionally referred to the Committee on Insurance. |
| 2026-02-27 | House | Prefiled. |
